Search: „100% Pass Quiz IIA - Pass-Sure IIA-CIA-Part3 - Business Knowledge for Internal Auditing Valid Braindumps Free 📊 Simply search for 【 IIA-CIA-Part3 】 for free download on ▷ www.pdfvce.com ◁ 🤨IIA-CIA-Part3 Pdf Dumps“

Press
16. January 2019

Series-A Investment for Munich-based Medical Technology Startup Mecuris

Mecuris GmbH, a commercial-stage Munich-based medical technology startup focusing on the digitalization of prosthetics and orthotics, successfully completes its Series-A financing round of EUR 3.6m. In addition to existing seed investors Bayern Kapital and High-Tech GrĂźnderfonds (HTGF), the new investors Vesalius Biocapital, Mulcan International Investments and one of the Top 5 hospital chains in Germany support now the innovative Mecuris approach. Every patient is unique! Therefore, the dem
 
Press
21. October 2019

HQS Quantum Simulations closes seed financing round

HQS enables chemical and material science companies with quantum chemical and advanced material simulations to use medium-term available NISQ processors UVC Partners, HTGF, and btov lead seed financing round Funding used to strengthen world-leading quantum simulation team From the development of more powerful batteries to highly efficient solar cells, finding new materials with specific predefined properties is of critical importance. So far our ability to design new materials using simu
 
Press
10. May 2011

Fresh capital for web store windeln.de

windeln.de, Germany's largest online web store for baby products, successfully completed its Series A financing. Led by the British venture capital company DN Capital, the High-Tech GrĂźnderfonds (HTGF) and a consortium of existing shareholders invested again in the company's growth. The Munich-based growth equity investor Acton Capital Partners could be gained as a new investor in this round. windeln.de was founded in 2010 by Konstantin Urban, Alexander Brand and Dagmar Mahnel and has been o
 
Press
8. September 2017

Reactive Robotics GmbH is on track

Clinical validation, market entry in Germany and further countries secured by second investment round with existing and new investors Founded in 2015 in Munich, Reactive Robotics GmbH is a medical device start-up with the corporate objective to provide the best possible Very Early Mobilization (VEM) to intensive care patients as early as 24 hours after hospital admission, directly in the patient’s bed. Amongst experts, VEM is regarded as one of the key factors contributing to the faster rec
 
Press
3. February 2011

Demand Response provider Entelios completes successful fundraising

Entelios AG, a European energy company, today announces the successful completion of its Series A financing round. The round was led by Yellow&Blue Investment Management, a Dutch clean energy investor, and High-Tech Gründerfonds, a German venture capital investor. Established in 2010, Munich-based Entelios is the first nationwide “Demand Response” aggregator and service provider. It has since taken a market leading position. Commenting on the fundraising, Oliver Stahl, founder and CE
 
Press
21. September 2012

Daimler acquires interest in startup company tiramizoo

Strategic partnership with the pioneer in the field of online services for local urban deliveries Daimler has acquired a minority interest Networking of local urban mobility and transport services creates comprehensive and efficient portfolio Daimler AG has acquired a minority interest in tiramizoo GmbH, a Munich-based startup company in the field of mobility services. tiramizoo pioneered a new business segment when it launched a year ago with a fully automated online booking platform fo
 
Press
30. September 2009

Neuhaus Partners and T-Venture invest in playnik.com

Hamburg-based venture capital company Neuhaus Partners today announced that it was investing in the start-up company wwg worldwidegames GmbH, Hamburg, in conjunction with the Connected Life and Work Fund managed by T-Venture. Playnik.com, the browser games community portal developed by wwg worldwidegames GmbH, offers both proprietary browser games and games developed by its partners in the fast-growing massively multiplayer online games (MMOG) market. The investment of the two venture capital fu
 
Press
18. December 2018

High-Tech GrĂźnderfonds and Think.Health Ventures together with Business Angels invest 3.3 million euros in a series A for the growth of PreOmics in Martinsried, Germany

PreOmics develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry. Today, the processing of samples for mass spectrometry is usually carried out according to homemade protocols. These processes are slow, not reproducible, not robust and cannot be automated. These solutions are therefore very time-consuming and costly, which can lead to the loss of valuable samples. PreOmics addresses these problems with a standardized technology that enables robust
 
Press
30. April 2019

ALENTIS Therapeutics launches, raising CHF 12.5m in a Series A to develop novel therapeutics in advanced liver disease and cancer

ALENTIS Therapeutics (“ALENTIS”), a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer, announced today the completion of a Series A financing of CHF 12.5million (Euro 11.1m; USD 12.5m). The Swiss venture capital firms BioMedPartners and BB Pureos Bioventures co-led the round and were joined by BPI France, Schroder Adveq and the German High-Tech Gründerfonds (HTGF). Markus L.E. Ewert, PhD, MBA has joined the company as Chief Executive Officer. M
 
Portfolio
30. September 2016

Immunic

Immunic Therapeutics is a clinical-stage biotech company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Immunic, Inc. is headquartered in New York. Its subsidiary, Immunic AG, is based in Graefelfing near Munich, Germany, where the company’s research and development activities are conducted. Additional subsidiaries are located in Halle/Saale, Germany, and Melbourne, Australia. Immunic is developing three small molecule pro
 
Press
15. May 2014

High-Tech Gruenderfonds Invests in the Next-Generation Malware Analysis Software of VMRay GmbH

VMRay GmbH has successfully closed its seed financing round. High-Tech Gruenderfonds (HTGF) invests in the development and marketing of the next-generation malware analysis software of VMRay, which has a special focus on complex 64-bit malware such as APTs and kernel rootkits. Organizations are upgrading their IT security in order to defend themselves against the surge in hacking attacks, cyber sabotage and spying assaults, which cause annual damages in the billions. The IT security software
 
Blog
4. June 2020

We will continue setting important trends

In an interview, High-Tech GrĂźnderfonds’ (HTGF) new Managing Director Guido Schlitzer talks about the first-ever Family Day held exclusively online, what the future holds for HTGF, and why sometimes you just have to give things a go. How was the first-ever Family Day held exclusively online? Guido Schlitzer: It was fantastic! The special thing about Family Day is that we’re able to bring together people who would have otherwise never met. We had wondered whether this i
 
Blog
22. March 2023

HTGF’s 700th investment: How oculai is revolutionising the construction industry

Marking High-Tech Gründerfonds’ 700th investment, the start-up oculai is revolutionising the construction industry with its innovative AI technology. Four of Germany’s five largest construction companies are already working with the construction tech start-up. We sat down for a chat with oculai founder Constantin Kauffmann and HTGF Senior Investment Management Dominik Lohle. Constantin, congratulations on the successful financing round. Can you explain what oculai does exactly?
 
Blog
20. December 2023

The year in review – 2023 

As the year draws to an end, we sat down for a chat with the High-Tech GrĂźnderfonds (HTGF) management team. Read on to find out what Romy Schnelle, Alex von Frankenberg and Guido Schlitzer had to say about how HTGF fared in 2023, which trends are becoming important, and what will really count for start-ups moving forward.   What would you say were the highlights for HTGF this year?   Alex von Frankenberg: Looking at the figures, 2023 was a good year for us –
 
Press
21. December 2009

New Portfolio Company for Leonardo Venture

Leonardo Venture GmbH & Co. KGaA is taking a share in GROHNO-Guss GmbH. It is already the second round of financing for GROHNO Guss. In addition to Leonardo Venture the company located in DĂźren also found two new investors: KfW and a business angel, the entrepreneur Matthias Popp who also became the new CEO on November 1st, 2009. Seedinvestor High-Tech GrĂźnderfonds approached Leonardo Venture which decided to become the new lead investor. Investment manager Andreas Quauke welcomes the joi
 
Blog
23. April 2024

Interview with Verena Pausder: Entrepreneurial awakening – make it in Germany!

Verena Pausder, Chairwoman of the German Startup Association At Family Day 2024, you’ll be calling for an “entrepreneurial awakening” and for companies to “make it in Germany”. How can this happen?If “Made in Germany” was a seal of quality in the past, then I believe that “Make it in Germany” should be our objective for the future.This can be achieved by supporting a start-up culture that welcomes diversity and talented individuals from around the world. Germany should s